drugset / Trial / NCT02479646
Pharmacokinetic / Pharmacodynamic Study Comparing MYL-1401H, EU-sourced Neulasta and US-licensed Neulasta
RandomizedCrossoverTriple-blindHealth-services research
Summary
This is a single center, double-blind, randomized, comparative pharmacokinetic and pharmacodynamic study of MYL-1401H and Neulasta (from EU and US source) in Normal Healthy Volunteers.
Timeline
- Start
- 2014-09
- Primary completion
- 2015-06
- Completion
- 2015-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MYL-1401H | Unknown | 2 mg | Subcutaneous |
Indications
No indication recorded.